Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Heather Forson

Physician Assistant, Surgical Birmingham, AL Physician Assistant

NPI 1265485601 CMS profile 10889644

619 19Th Street South, Birmingham, AL 35233

Open in the dashboard

General payments

$8,292

447 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Heather Forson of Birmingham, AL is reported in the CMS Open Payments database as having received $8,292 across 447 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,679 85
2024 General $1,220 72
2023 General $1,794 89
2022 General $1,962 108
2021 General $1,636 93

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Heather Forson
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Heather Forson were reported at $1,679. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Heather Forson Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,636 $111 $36–$285 $132
2022 $1,962 $126 $44–$350 $149
2023 $1,794 $137 $47–$355 $160
2024 $1,220 $146 $49–$384 $164
2025 $1,679 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,493 98 payments
  2. Collegium Pharmaceutical, Inc. $1,433 99 payments
  3. AbbVie, Inc. $1,161 52 payments
  4. Abbott Laboratories $486 9 payments
  5. Scilex Pharmaceuticals Inc. $423 25 payments
  6. IBSA Pharma Inc. $388 21 payments
  7. Boston Scientific Corporation $384 15 payments
  8. Idorsia Pharmaceuticals US Inc $333 16 payments
  9. RedHill Biopharma Inc. $255 15 payments
  10. Amgen Inc. $253 7 payments
  11. Other $1,682 90 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,292 447 payments
Products named General payments · program years 2021–2025
  1. RELISTOR Gastroenterology $1,165 88 payments
  2. XTAMPZA $1,049 72 payments
  3. RELISTOR Gastroenterology $840 52 payments
  4. UBRELVY $722 26 payments
  5. QULIPTA $467 20 payments
  6. Licart $388 21 payments
  7. BELBUCA $383 27 payments
  8. ZTLido $381 23 payments
  9. Tirosint $339 18 payments
  10. QUVIVIQ $333 16 payments
  11. Other $4,011 190 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

447 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record